Schizophrenia is a form of mental disorder that is behaviorally characterized by abnormal
behavior, such as social function deficits or other behaviors that are disconnected from …

Oxytocin (OXT) and arginine-vasopressin (AVP) are structurally homologous peptide
hormones synthesized in the hypothalamus. Nowadays, the role of OXT and AVP in the …

Schizophrenia is a disabling, heterogeneous disorder with clinical features that can be
parsed into three domains: positive symptoms, negative symptoms, and cognitive deficits …

Schizophrenia is a severe mental illness that causes major functional impairment. Current
pharmacologic treatments are inadequate, particularly for addressing negative and cognitive …

Schizophrenia is a heterogeneous, debilitating disorder characterized by three distinct sets
of clinical features: positive symptoms, negative symptoms, and cognitive deficits. Extant …

While there is growing interest in the potential for intranasal oxytocin (IN-OT) to improve
social cognition and neurocognition (ie, nonsocial cognition) in schizophrenia, the extant …

The high prevalence of metabolic syndrome in persons with schizophrenia has spurred
investigational efforts to study the mechanism beneath its pathophysiology. Early psychosis …

Cognitive impairments associated with schizophrenia (CIAS) represent a central element of
the symptomatology of this severe mental disorder. CIAS substantially determine the …

Intranasal administration of the neuropeptide oxytocin (OT) has yielded inconsistent effects
on social cognition and general cognition in individuals with schizophrenia (SZ). Few …

Social recognition is the sensitive domains of complex behavior critical for identification,
interpretation and storage of socially meaningful information. Social recognition develops …